Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients

Butler et al., New England Journal of Medicine, doi:10.1056/NEJMoa2502457 (results released 9/10/2025), CanTreatCOVID, NCT05614349, Sep 2025
Death/hospitalization 52% improvement lower risk ← → higher risk Recovery, day 14 42% Recovery 34% Recovery time 33% no CI Paxlovid  CanTreatCOVID  EARLY TREATMENT RCT Is early treatment with paxlovid beneficial for COVID-19? RCT 667 patients in the United Kingdom (December 2021 - September 2024) Improved recovery with paxlovid (p=0.000018) c19early.org Butler et al., New England J. Medicine, Sep 2025 0 0.5 1 1.5 2+ RR
Results for the CanTreatCOVID trial. See Butler et al. for details.
Standard of Care (SOC) for COVID-19 in the study country, the United Kingdom, is very poor with very low average efficacy for approved treatments2. The United Kingdom focused on expensive high-profit treatments, approving only one low-cost early treatment, which required a prescription and had limited adoption. The high-cost prescription treatment strategy reduces the probability of early treatment due to access and cost barriers, and eliminates complementary and synergistic benefits seen with many low-cost treatments.
risk of death/hospitalization, 51.7% lower, RR 0.48, p = 0.39, treatment 2 of 343 (0.6%), control 4 of 324 (1.2%), NNT 153, odds ratio converted to relative risk, day 28.
risk of no recovery, 42.2% lower, RR 0.58, p < 0.001, treatment 73 of 345 (21.2%), control 112 of 306 (36.6%), NNT 6.5, day 14.
risk of no recovery, 34.4% lower, RR 0.66, p < 0.001, treatment 86 of 277 (31.0%), control 115 of 245 (46.9%), NNT 6.3, inverted to make RR<1 favor treatment, odds ratio converted to relative risk, no early sustained recovery.
recovery time, 33.3% lower, relative time 0.67, treatment 343, control 324.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Butler et al., 10 Sep 2025, Randomized Controlled Trial, United Kingdom, peer-reviewed, 42 authors, study period 8 December, 2021 - 30 September, 2024, trial NCT05614349 (history) (CanTreatCOVID).
$0 $500 $1,000+ Efficacy vs. cost for COVID-19 treatment protocols c19early.org April 2026 United Kingdom Russia Sudan Angola Colombia Kenya Mozambique Peru Philippines Vietnam France Italy Japan Canada China Uzbekistan Iran Nepal Bangladesh Ethiopia Ghana Germany Mexico South Korea Saudi Arabia Algeria Morocco Yemen Poland Venezuela India DR Congo Madagascar Thailand Uganda Egypt Nigeria Bolivia Zambia Austria Croatia Fiji Bosnia-Herzegovina Ukraine Côte d'Ivoire Bulgaria Greece Slovakia Singapore Iceland New Zealand Trinidad and Tobago Mongolia Czechia Israel Belarus North Macedonia Hong Kong Qatar Panama Serbia CAR The United Kingdom favored high-profit treatments.The average efficacy of treatments was very low.High-cost protocols reduce early treatment, andforgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
$0 $500 $1,000+ Efficacy vs. cost for COVID-19treatment protocols worldwide c19early.org April 2026 United Kingdom Russia Sudan Angola Colombia Kenya Mozambique Peru Vietnam Brazil France Italy Japan Canada China Uzbekistan Iran Nepal Bangladesh Ethiopia Ghana Germany Mexico South Korea Saudi Arabia Algeria Morocco Yemen Poland Venezuela India DR Congo Madagascar Thailand Uganda Egypt Nigeria Bolivia Austria Fiji Georgia Ukraine Côte d'Ivoire Eritrea Bulgaria Greece Slovakia Singapore Iceland New Zealand Mongolia Czechia Israel Belarus North Macedonia Hong Kong Qatar Panama Serbia CAR The UK favored high-profit treatments.The average efficacy was very low.High-cost protocols reduce early treatment,and forgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
DOI record: { "DOI": "10.1056/nejmoa2502457", "ISSN": [ "0028-4793", "1533-4406" ], "URL": "http://dx.doi.org/10.1056/NEJMoa2502457", "alternative-id": [ "10.1056/NEJMoa2502457" ], "author": [ { "ORCID": "https://orcid.org/0000-0002-0102-3453", "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "authenticated-orcid": false, "family": "Butler", "given": "Christopher C.", "sequence": "first" }, { "affiliation": [ { "name": "Upstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto" }, { "name": "Department of Family and Community Medicine, St. Michael’s Hospital, Toronto" }, { "name": "Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto" }, { "name": "Dalla Lana School of Public Health, University of Toronto, Toronto" } ], "family": "Pinto", "given": "Andrew D.", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Harris", "given": "Victoria", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Holmes", "given": "Jane", "sequence": "additional" }, { "affiliation": [ { "name": "Respiratory Trials Unit, Nuffield, Department of Medicine, University of Oxford, Oxford, United Kingdom" }, { "name": "Oxford National Institute for Health and Care Research Biomedical Research Centre, Oxford, United Kingdom" }, { "name": "Chinese Academy of Medicine Oxford Institute, University of Oxford, Oxford, United Kingdom" } ], "family": "Rahman", "given": "Najib M.", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Cureton", "given": "Lucy", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Hayward", "given": "Gail", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Medicine, University of Cambridge, Cambridge, United Kingdom" } ], "family": "Richards", "given": "Duncan B.", "sequence": "additional" }, { "affiliation": [ { "name": "Institute of Immunity and Transplantation, University College London, London" } ], "family": "Lowe", "given": "David M.", "sequence": "additional" }, { "affiliation": [ { "name": "Institute of Immunity and Transplantation, University College London, London" } ], "family": "Standing", "given": "Joseph F.", "sequence": "additional" }, { "affiliation": [ { "name": "Infection, Inflammation and Immunology, UCL Great Ormond Street Institute of Child Health, London" } ], "family": "Breuer", "given": "Judith", "sequence": "additional" }, { "affiliation": [ { "name": "Centre for Trials Research, Cardiff University, Cardiff, United Kingdom" } ], "family": "Hood", "given": "Kerenza", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Png", "given": "May Ee", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Petrou", "given": "Stavros", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-6072-1430", "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" }, { "name": "Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa" } ], "authenticated-orcid": false, "family": "Dorward", "given": "Jienchi", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Patel", "given": "Mahendra G.", "sequence": "additional" }, { "affiliation": [ { "name": "National Institute Health and Care Research Delivery Network, London" }, { "name": "Windrush Medical Practice, Witney, United Kingdom" }, { "name": "Royal College of General Practitioners, London" } ], "family": "Thomas", "given": "Nicholas P.B.", "sequence": "additional" }, { "affiliation": [ { "name": "National Institute Health and Care Research Delivery Network, London" }, { "name": "Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom" } ], "family": "Evans", "given": "Philip", "sequence": "additional" }, { "affiliation": [ { "name": "School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, United Kingdom" } ], "family": "Hart", "given": "Nigel D.", "sequence": "additional" }, { "affiliation": [ { "name": "General Practice and Primary Care, School of Health and Wellbeing, MVLS, University of Glasgow, Glasgow, United Kingdom" } ], "family": "Jani", "given": "Bhautesh D.", "sequence": "additional" }, { "affiliation": [ { "name": "Upstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto" }, { "name": "Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto" }, { "name": "Dalla Lana School of Public Health, University of Toronto, Toronto" } ], "family": "Hosseini", "given": "Banafshe", "sequence": "additional" }, { "affiliation": [ { "name": "Faculty of Medicine, University of British Columbia, Vancouver, Canada" } ], "family": "Murthy", "given": "Srinivas", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Family Medicine, University of Calgary, Calgary, AB, Canada" }, { "name": "Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada" } ], "family": "McBrien", "given": "Kerry", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada" } ], "family": "Condon", "given": "Amanda", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal" } ], "family": "McDonald", "given": "Emily G.", "sequence": "additional" }, { "affiliation": [ { "name": "Memorial University of Newfoundland, St. John’s, Canada" } ], "family": "Daley", "given": "Peter", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto" }, { "name": "Department of Family and Community Medicine, North York General Hospital, Toronto" } ], "family": "Greiver", "given": "Michelle", "sequence": "additional" }, { "affiliation": [ { "name": "Dalla Lana School of Public Health, University of Toronto, Toronto" }, { "name": "Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom" } ], "family": "da Costa", "given": "Bruno R.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-5401-2996", "affiliation": [ { "name": "Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto" }, { "name": "Dalla Lana School of Public Health, University of Toronto, Toronto" } ], "authenticated-orcid": false, "family": "Selby", "given": "Peter", "sequence": "additional" }, { "affiliation": [ { "name": "Dalla Lana School of Public Health, University of Toronto, Toronto" }, { "name": "Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom" } ], "family": "Jüni", "given": "Peter", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-2267-4239", "affiliation": [ { "name": "Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal" } ], "authenticated-orcid": false, "family": "Lee", "given": "Todd C.", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada" } ], "family": "Shi", "given": "Haolun", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-2794-1439", "affiliation": [ { "name": "Berry Consultants, Austin, TX" } ], "authenticated-orcid": false, "family": "Detry", "given": "Michelle A.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4325-9568", "affiliation": [ { "name": "Berry Consultants, Austin, TX" } ], "authenticated-orcid": false, "family": "Saunders", "given": "Christina T.", "sequence": "additional" }, { "affiliation": [ { "name": "Berry Consultants, Austin, TX" } ], "family": "Fitzgerald", "given": "Mark", "sequence": "additional" }, { "affiliation": [ { "name": "Berry Consultants, Austin, TX" } ], "family": "Berry", "given": "Nicholas S.", "sequence": "additional" }, { "affiliation": [ { "name": "Berry Consultants, Austin, TX" }, { "name": "Department of Biostatistics, Vanderbilt University School of Medicine, Nashville" } ], "family": "Saville", "given": "Benjamin R.", "sequence": "additional" }, { "affiliation": [ { "name": "Centre for Experimental Therapeutics, University of Liverpool, Liverpool, United Kingdom" } ], "family": "Khoo", "given": "Saye H.", "sequence": "additional" }, { "affiliation": [ { "name": "Lifespan and Population Health Unit, University of Nottingham School of Medicine, Nottingham, United Kingdom" } ], "family": "Nguyen-Van-Tam", "given": "Jonathan S.", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Hobbs", "given": "F.D. Richard", "sequence": "additional" }, { "affiliation": [ { "name": "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom" } ], "family": "Yu", "given": "Ly-Mee", "sequence": "additional" }, { "affiliation": [ { "name": "Primary Care Research Centre, University of Southampton, Southampton, United Kingdom" } ], "family": "Little", "given": "Paul", "sequence": "additional" } ], "container-title": "New England Journal of Medicine", "container-title-short": "N Engl J Med", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2026, 4, 22 ] ], "date-time": "2026-04-22T21:00:23Z", "timestamp": 1776891623000 }, "deposited": { "date-parts": [ [ 2026, 4, 22 ] ], "date-time": "2026-04-22T21:00:45Z", "timestamp": 1776891645000 }, "funder": [ { "DOI": "10.13039/501100000024", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100000024", "id-type": "DOI" } ], "name": "Canadian Institutes of Health Research" }, { "DOI": "10.13039/501100000276", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100000276", "id-type": "DOI" } ], "name": "National Institute for Health and Care Research" } ], "indexed": { "date-parts": [ [ 2026, 4, 22 ] ], "date-time": "2026-04-22T21:40:09Z", "timestamp": 1776894009980, "version": "3.51.2" }, "is-referenced-by-count": 0, "issue": "16", "issued": { "date-parts": [ [ 2026, 4, 23 ] ] }, "journal-issue": { "issue": "16", "published-print": { "date-parts": [ [ 2026, 4, 23 ] ] } }, "language": "en", "license": [ { "URL": "http://www.nejmgroup.org/legal/terms-of-use.htm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 4, 23 ] ], "date-time": "2026-04-23T00:00:00Z", "timestamp": 1776902400000 } } ], "link": [ { "URL": "http://www.nejm.org/doi/pdf/10.1056/NEJMoa2502457", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "150", "original-title": [], "page": "1583-1594", "prefix": "10.1056", "published": { "date-parts": [ [ 2026, 4, 23 ] ] }, "published-print": { "date-parts": [ [ 2026, 4, 23 ] ] }, "publisher": "Massachusetts Medical Society", "reference": [ { "key": "e_1_3_4_2_2", "unstructured": "World Health Organization. COVID-19 epidemiological update — 17 September 2024 (https://www.who.int/publications/m/item/covid-19-epidemiological-update-edition-171)." }, { "DOI": "10.1056/NEJMoa2118542", "doi-asserted-by": "publisher", "key": "e_1_3_4_3_2" }, { "DOI": "10.1126/science.abl4784", "doi-asserted-by": "publisher", "key": "e_1_3_4_4_2" }, { "key": "e_1_3_4_5_2", "unstructured": "National Institute for Health and Care Excellence (NICE). Nirmatrelvir plus ritonavir sotrovimab and tocilizumab for treating COVID-19. Technology appraisal guidance no. TA878. February 26 2026 (https://www.nice.org.uk/guidance/ta878/chapter/1-Recommendations)." }, { "DOI": "10.1093/jac/dkae163", "doi-asserted-by": "publisher", "key": "e_1_3_4_6_2" }, { "DOI": "10.1093/jac/dkac437", "doi-asserted-by": "publisher", "key": "e_1_3_4_7_2" }, { "key": "e_1_3_4_8_2", "unstructured": "Bhimraj A Falck-Ytter Y Baden LR et al. IDSA guidelines on the treatment and management of patients with COVID-19. Arlington VA: Infectious Diseases Society of America October 14 2025 (https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/)." }, { "DOI": "10.1056/NEJMoa2309003", "doi-asserted-by": "publisher", "key": "e_1_3_4_9_2" }, { "article-title": "Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.", "author": "Reis S", "first-page": "CD015395", "journal-title": "Cochrane Database Syst Rev", "key": "e_1_3_4_10_2", "unstructured": "Reis S, Metzendorf MI, Kuehn R, et al. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19. Cochrane Database Syst Rev 2023;11:CD015395-CD015395.38032024", "volume": "11", "year": "2023" }, { "DOI": "10.1136/bmjopen-2022-069176", "doi-asserted-by": "publisher", "key": "e_1_3_4_11_2" }, { "DOI": "10.1016/S0140-6736(22)02597-1", "doi-asserted-by": "publisher", "key": "e_1_3_4_12_2" }, { "key": "e_1_3_4_13_2", "unstructured": "Hosseini B Condon A da Costa BR et al. Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings. BMJ Open 2025;15(8):e097134-e097134.40754325" }, { "DOI": "10.1016/S2213-2600(21)00310-6", "doi-asserted-by": "publisher", "key": "e_1_3_4_14_2" }, { "DOI": "10.1016/S0140-6736(21)00461-X", "doi-asserted-by": "publisher", "key": "e_1_3_4_15_2" }, { "DOI": "10.1016/j.jinf.2024.106130", "doi-asserted-by": "publisher", "key": "e_1_3_4_16_2" }, { "DOI": "10.3399/BJGP.2022.0083", "doi-asserted-by": "publisher", "key": "e_1_3_4_17_2" }, { "DOI": "10.1016/S0140-6736(21)01744-X", "doi-asserted-by": "publisher", "key": "e_1_3_4_18_2" }, { "DOI": "10.1016/j.jinf.2024.106248", "doi-asserted-by": "publisher", "key": "e_1_3_4_19_2" }, { "DOI": "10.1038/s41598-025-09275-6", "doi-asserted-by": "publisher", "key": "e_1_3_4_20_2" }, { "DOI": "10.1093/cid/ciae551", "doi-asserted-by": "publisher", "key": "e_1_3_4_21_2" }, { "DOI": "10.1016/j.jclinepi.2008.12.011", "doi-asserted-by": "publisher", "key": "e_1_3_4_22_2" }, { "DOI": "10.1056/NEJMra1510059", "doi-asserted-by": "publisher", "key": "e_1_3_4_23_2" }, { "DOI": "10.1001/jama.287.5.622", "doi-asserted-by": "publisher", "key": "e_1_3_4_24_2" }, { "DOI": "10.12688/f1000research.17611.2", "doi-asserted-by": "publisher", "key": "e_1_3_4_25_2" }, { "DOI": "10.1186/s12879-023-08835-3", "doi-asserted-by": "publisher", "key": "e_1_3_4_26_2" }, { "DOI": "10.1016/S1473-3099(21)00705-2", "doi-asserted-by": "publisher", "key": "e_1_3_4_27_2" } ], "reference-count": 26, "references-count": 26, "relation": {}, "resource": { "primary": { "URL": "http://www.nejm.org/doi/10.1056/NEJMoa2502457" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients", "type": "journal-article", "volume": "394" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit